Citi Upgrades Dimension Therapeutics (DMTX) to Neutral (Yesterday)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Citi Upgrades Dimension Therapeutics (DMTX) to Neutral (Yesterday)

Regenxbio (RGNX) Confirms it Will Not Increase Consideration for Dimension Therapeutics (DMTX)

October 2, 2017 8:33 AM EDT

REGENXBIO Inc. (Nasdaq: RGNX) today announced that Dimension Therapeutics, Inc. (Nasdaq: DMTX) notified REGENXBIO that it has determined that it has received a superior proposal as defined in the merger agreement under which REGENXBIO would have acquired Dimension in an all-stock transaction for an implied value of approximately $3.41 per share based on the closing stock price of REGENXBIO stock on August 24, 2017.

Late yesterday, Dimension notified REGENXBIO that its board of directors determined that the recently amended proposal from Ultragenyx Pharmaceutical Inc. (Nasdaq:... More